Loading data…
Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.
$174.27M net income for the year ended December 27, 2025. These are reported results, not a forecast or a stock recommendation.
Latest-filed standard financial facts · USD
Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.
Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.
| Reported period | Reported value | Filed | Source |
|---|---|---|---|
| December 29, 2024 – December 27, 2025 | $696,853,000 | February 18, 2026 | 10-K ↗ |
| December 31, 2023 – December 28, 2024 | $625,807,000 | February 18, 2026 | 10-K ↗ |
| December 27, 2022 – December 30, 2023 | $460,055,000 | February 18, 2026 | 10-K ↗ |
| December 26, 2021 – December 31, 2022 | $357,521,000 | February 19, 2025 | 10-K ↗ |
| December 27, 2020 – December 25, 2021 | $282,502,000 | February 21, 2024 | 10-K ↗ |
| December 29, 2019 – December 26, 2020 | $248,811,000 | February 22, 2023 | 10-K ↗ |
| December 30, 2018 – December 28, 2019 | $199,676,000 | February 16, 2022 | 10-K ↗ |
| December 31, 2017 – December 29, 2018 | $153,181,000 | February 18, 2021 | 10-K ↗ |
One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.
Concept: us-gaap:Revenues · Retrieved October 14, 2026
Response SHA-256: b06e063a6d131b5a898269149242bf8d588aca401bcbf127028a748238368766
Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.